临床外科杂志 ›› 2022, Vol. 30 ›› Issue (5): 471-474.doi: 10.3969/j.issn.1005-6483.2022.05.020

• 论著 • 上一篇    下一篇

肝癌调控细胞凋亡抑制因子1的表达及其对细胞增殖和凋亡的影响

  

  1. 636400 四川省平昌县人民医院肝胆外科(杨刚);川北医学院附属医院肝胆外科,川北医学院肝胆胰肠研究所(杨刚、熊永福);川北医学院附属医院健康管理中心(王冠、李芸、雷蓉、柳弥)
  • 收稿日期:2021-04-20 接受日期:2021-04-20 出版日期:2022-05-20 发布日期:2022-06-20
  • 通讯作者: 王冠,Email:313436058@qq.com

Study on the expression of TP53 regulation of apoptosis inhibitor 1 in hepatoma cells and its effect on proliferation and apoptosis

  1. Department of Hepatobiliary Surgery,Pingchang County People’s Hospital,Sichuan,Pingchang 636400,China
  • Received:2021-04-20 Accepted:2021-04-20 Online:2022-05-20 Published:2022-06-20

摘要: [摘要] 目的 探究TP53调控细胞凋亡抑制因子1(TRIAP1)对肝癌细胞Huh7和HepG2增殖和侵袭能力的影响。方法 本研究首先使用TCGA数据库分析肿瘤组织和正常组织中TRIAP1的表达差异,分析TRIAP1表达与肝癌病人预后的相关性。通过在肝癌细胞Huh7和HepG2中转染siRNA及siControl 构建敲低TRIAP1的细胞系,Western blot验证转染TRIAP1 siRNA的敲低效率及其他相关蛋白水平。Capase3/7活性细胞凋亡试剂盒、Annex inV/PI法检测在肝癌细胞中敲低TRIAP1对肝癌细胞凋亡的影响,CCK8检测TRIAP1对肝癌细胞增殖的影响。结果 TCGA数据库分析显示,肝癌细胞中TRIAP1表达上调,且与肝癌病人预后呈负相关。在肝癌细胞Huh7和HepG2中敲低TRIAP1实验组TRIAP1的表达比对照组表达明显下降,敲低TRIAP1后实验组中p21在mRNA和蛋白表达水平均出现上调,敲低TRIAP1实验组的增殖能力显著下降,而凋亡细胞数量明显增加。结论 TRIAP1在肝癌细胞中表达上调,负调控细胞周期相关基因p21的表达调节肿瘤细胞周期,抑制TRIAP1可显著上调p21,抑制肝癌细胞增殖能力,促进肝癌细胞凋亡进程。

关键词: 细胞凋亡抑制因子1, 肝癌, p53, p21

Abstract: [Abstract] Objective To investigate the effects of TP53 regulation of apoptosis inhibitor 1(TRIAP1) on the proliferation and invasion ability of hepatoma cells Huh7 and HepG2.Methods In this study,the difference of TRIAP1 expression in tumor tissues and normal tissues was analyzed using TCGA database,and the correlation between TRIAP1 and prognosis of HCC patients was analyzed.TRIAP1 knockdown cell lines were constructed by transfection with siRNA and control group.Western blot was used to verify knockdown efficiency of TRIAP1 siRNA transfection and the levels of other related proteins.The effect of TRIAP1 on the apoptosis of HCC cells was detected by Capase 3/7 active cell apoptosis kit and Annex INV /PI assay,and the effect of TRIAP1 on the proliferation of HCC cells was detected by CCK8.Results TCGA database analysis showed that TRIAP1 expression was up-regulated in HCC cells,and was negatively correlated with prognosis of HCC patients.siTRIAP1 was transfected into Huh7 and HepG2 to downregulate TRIAP1 expression..The mRNA and protein expression levels of p21 in the TRIAP1 knockdown group were significantly up-regulated,and the proliferation ability of the TRIAP1 knockdown group was decreased,while the number of apoptotic cells was increased.Conclusion The expression of TRIAP1 is up-regulated in HCC cells,and the expression of cell cycle related p21 expression is decreased and then regulate the tumor cell cycle.Inhibition of TRIAP1 can significantly up-regulate p21,inhibit the proliferation ability of HCC cells,and promote the apoptosis process.

Key words: TP53 regulation of apoptosis inhibitor 1, hepatocellular carcinoma, p53, p21

[1] 蔡秀军 张斌 陈鸣宇 曹佳胜. 美国国家综合癌症网络肝胆肿瘤临床实践指南2021.V2版更新解读(肝癌部分)[J]. 临床外科杂志, 2022, 30(1): 4-6.
[2] 李江, 陈耀兵, 陈丽君等. 自体肿瘤浸润淋巴细胞联合抗程序性死亡受体1单抗治疗晚期肝癌的临床研究[J]. 临床外科杂志, 2021, 29(8): 743-747.
[3] 孙启刚, 符策雄, 郑进方. 绕肝悬吊前入路右半肝切除术在肝癌手术中的应用研究[J]. 临床外科杂志, 2021, 29(8): 748-750.
[4] 潘乐玉, 郭德良, 张玉仙等. 肝动脉结扎联合门静脉部分阻断对肝再生及肝细胞癌生长的影响[J]. 临床外科杂志, 2021, 29(4): 367-371.
[5] 王观宇. 肝癌转化治疗的策略和现状[J]. 临床外科杂志, 2021, 29(11): 1012-1014.
[6] 方小三 王小明 韩婷 蒋彬 王冠男 奚士航. 原发性肝癌病人腹腔镜肝叶切除术后并发胆漏的风险预测模型构建[J]. 临床外科杂志, 2021, 29(11): 1030-1033.
[7] 李柱威 尹东亮 黎笑兰 王金林 林志强 卢沛林 尹润龙. 预存式自体输血对肝癌手术病人炎症反应及免疫功能的影响[J]. 临床外科杂志, 2021, 29(11): 1034-1037.
[8] 郭张有 洪源. 肝硬化门静脉高压症肝癌手术切除全程评估和管理的进展[J]. 临床外科杂志, 2021, 29(11): 1092-1095.
[9] 郭杨 韩磊 常轶群 吴军 张巍. 原发性肝癌合并先天性右侧膈肌缺损行肝部分切除术一例[J]. 临床外科杂志, 2021, 29(11): 1099-1100.
[10] 国际肝胆胰协会中国分会 全国肝病和肝癌大数据联盟. 原发性肝癌临床标准化术语[J]. 临床外科杂志, 2020, 28(8): 722-724.
[11] 鲍伟. 功能性残余肝脏体积与脾脏体积比对病人术后肝功能不全以及肝功能恢复的预测价值[J]. 临床外科杂志, 2020, 28(8): 750-752.
[12] 黄志勇, 陈孝平. 肝硬化与肝癌肝切除的科学决策[J]. 临床外科杂志, 2019, 27(8): 631-633.
[13] 张海峰, 宋栋达, 刘荣. 达芬奇机器人右半肝切除技巧与经验[J]. 临床外科杂志, 2019, 27(8): 634-637.
[14] 肖永胜, 周俭. 肝移植术后肝癌复发转移与PD-1/PD-L1抑制剂免疫治疗[J]. 临床外科杂志, 2019, 27(8): 642-645.
[15] 严峻, 柏淳, 李锋, 傅文喜, 余小红. 经皮肝动脉化疗栓塞术联合索拉非尼治疗肝癌的疗效及安全性观察[J]. 临床外科杂志, 2019, 27(8): 668-670.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 李光焰;张安平;王祥峰;等. 直肠癌切除术后吻合口狭窄14例分析[J]. 临床外科杂志, 2016, 24(10): 772 .
[2] 肖国栋;刘国辉. 跗骨窦切口联合经皮置钉技术微创治疗跟骨骨折的临床疗效分析[J]. 临床外科杂志, 2016, 24(10): 783 .
[3] 杨钦;张再重;王烈. 空肠间置术在Siewert Ⅱ型食管胃结合部腺癌中的应用[J]. 临床外科杂志, 2016, 24(11): 816 .
[4] 应敏刚;杨春康. 腹腔镜胃癌根治术并发症的防治策略[J]. 临床外科杂志, 2016, 24(11): 819 .
[5] 石汉平. 胃癌围手术期营养治疗[J]. 临床外科杂志, 2016, 24(11): 821 .
[6] 林伟箭;洪雪辉;许淑镇;等. 吸引器在腹腔镜胃癌根治术中的应用体会[J]. 临床外科杂志, 2016, 24(11): 824 .
[7] 方军;余阳;许涛;等. 小野寺营养预后指数在胃癌患者预后评估中的价值[J]. 临床外科杂志, 2016, 24(11): 831 .
[8] 王维君;那光玮;何科基;等. 根治性淋巴结清扫联合脾切除在残胃癌手术中的临床意义探究[J]. 临床外科杂志, 2016, 24(11): 835 .
[9] 吴超;谢迪;汪全新;等. 胃癌肝转移的临床病理特征及危险因素分析[J]. 临床外科杂志, 2016, 24(11): 839 .
[10] 许州;陈谦学;李明昌;等. 胶质瘤中miR383与其靶向circ_001634相互调控机制及作用研究[J]. 临床外科杂志, 2016, 24(11): 844 .